263 related articles for article (PubMed ID: 21804109)
1. A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
Verschuren JJ; Trompet S; Wessels JA; Guchelaar HJ; de Maat MP; Simoons ML; Jukema JW
Eur Heart J; 2012 Jan; 33(2):165-75. PubMed ID: 21804109
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics and the potential for personalized therapeutics in cardiovascular disease.
Kayser SR
Prog Cardiovasc Nurs; 2007; 22(2):104-7. PubMed ID: 17541322
[No Abstract] [Full Text] [Related]
3. Pharmacogenetics of the antiplatelet effect of aspirin.
Würtz M; Kristensen SD; Hvas AM; Grove EL
Curr Pharm Des; 2012; 18(33):5294-308. PubMed ID: 22724416
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management.
Humma LM; Terra SG
Am J Health Syst Pharm; 2002 Jul; 59(13):1241-52. PubMed ID: 12116890
[TBL] [Abstract][Full Text] [Related]
5. The genetics of aspirin resistance.
Goodman T; Sharma P; Ferro A
Int J Clin Pract; 2007 May; 61(5):826-34. PubMed ID: 17391325
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics in cardiovascular diseases.
Mukherjee D; Topol EJ
Curr Probl Cardiol; 2003 May; 28(5):317-47. PubMed ID: 14614445
[No Abstract] [Full Text] [Related]
7. Clinical application of cardiovascular pharmacogenetics.
Voora D; Ginsburg GS
J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular therapeutics.
Shakur R; Cockrum E; Scott D
Br J Hosp Med (Lond); 2008 Sep; 69(9):M136-40. PubMed ID: 18819300
[No Abstract] [Full Text] [Related]
9. Cardiovascular pharmacogenetics.
Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Pharmacogenomics--Implications for Patients With CKD.
Cavallari LH; Mason DL
Adv Chronic Kidney Dis; 2016 Mar; 23(2):82-90. PubMed ID: 26979147
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of Lipid-lowering Therapies.
Ordovas JM; Shen H
Curr Atheroscler Rep; 2002 May; 4(3):183-92. PubMed ID: 11931715
[TBL] [Abstract][Full Text] [Related]
12. Use of genetic data to guide therapy in arterial disease.
Ross S; Nejat S; Paré G
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S281-9. PubMed ID: 26149037
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G
Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450-mediated cardiovascular drug interactions.
Scheen AJ
Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1065-82. PubMed ID: 21810031
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based medical therapy of patients with acute coronary syndromes.
Ramanath VS; Eagle KA
Am J Cardiovasc Drugs; 2007; 7(2):95-116. PubMed ID: 17503881
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).
Lamoureux F; Duflot T;
Therapie; 2017 Apr; 72(2):257-267. PubMed ID: 28237404
[TBL] [Abstract][Full Text] [Related]
17. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG
Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788
[TBL] [Abstract][Full Text] [Related]
19. Personalized medicine and antiplatelet therapy: ready for prime time?
Verstuyft C; Simon T; Kim RB
Eur Heart J; 2009 Aug; 30(16):1943-63. PubMed ID: 19638479
[No Abstract] [Full Text] [Related]
20. Pharmacogenetics of chronic cardiovascular drugs: applications and implications.
Zineh I; Johnson JA
Expert Opin Pharmacother; 2006 Aug; 7(11):1417-27. PubMed ID: 16859425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
